Looking at the two year chart this stock is setting up nicely for the next leg up. Shareholders are very much overdue for complete trial readouts for PDD and Rett Syndrome. When working with the Fda for BTD or AA Im sure they frown on hints by companies and even if they didnt, its still not Dr Misslings style unless its locked down for sure.
Market Data 
Markets 
AI
